Compliance considerations with hormone replacement therapy

Menopause

Volumn 5, Issue 2, 1998, Pages 102-106

  Karakoç, Birgül ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Compliance; Hormone replacement therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; TRANSDERMAL DRUG ADMINISTRATION; TURKEY (REPUBLIC); UTERUS BLEEDING;

ADULT; AGED; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; INTERVIEWS; MIDDLE AGED; NEOPLASMS; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE; TIME FACTORS; TURKEY; UTERINE HEMORRHAGE;

EID: 0031778853     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Lobo RA. Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 1995;173:982-90.
2. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
3. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044-9.
4. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.
5. Nachtigall LE. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol 1990;75:77S-80S.